Authors
Loading...
Preclinical evaluation demonstrates safe, repeat-dose mRNA delivery with enhanced endosomal escape in non-human primates, highlighting potential for chronic mRNA-based therapies.
Sabnis et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: